ctDNA dynamics during neoadjuvant therapy in locally advanced solid tumors: a prospective cohort study
Tracking cancer DNA in blood during treatment reveals in real-time how well therapy is working.
This prospective study evaluates ctDNA dynamics during neoadjuvant therapy, showing that ctDNA clearance patterns correlate with pathological response. The findings support ctDNA as a real-time biomarker for treatment monitoring.
What the study was
- Study design
- Prospective cohort
- Population
- Locally advanced solid tumor patients undergoing neoadjuvant therapy
- Category
- Early Detection
- Maturity
- Validated
Why it surfaced
Prospective ctDNA monitoring study adding to growing evidence base. Medium confidence due to partial metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.